ERK1 and ERK2 activities are key to ovarian functions and fertility

May 14, 2009

HOUSTON -(May 15, 2009) - Two enzymes called extracellular signal-regulated kinases (ERK1 and ERK2) are critical factors in a pathway that induces ovulation, maturation of the mammalian egg (oocyte) and other activities key to ovarian function and female fertility, said a group of researchers at Baylor College of Medicine (BCM) in a report that appears today in the journal Science.

"This finding could provide clues to developing new contraceptives and understanding infertility in some women with irregular menstrual cycles," said Dr. JoAnne S. Richards, (http://www.bcm.edu/mcb/?PMID=7691), professor of molecular and cellular biology at BCM and the paper's senior author.

Block everything

"There are other genes that when mutated can block ovulation and other activities involved with oocyte maturation or formation of corpora lutea," said Richards and Dr. Heng-Yu Fan, a senior postdoctoral fellow in Richard's laboratory and the paper's first author. "But these are the only ones so potent that they can block everything." (The corpora lutea [luteum in the singular] are a yellow mass of cells that forms from the follicle after the release of an egg. It secretes the hormone progesterone.

Previous studies had shown that mice that lacked ERK1 are viable and can conceive but those without ERK2 died as embryos.

"We thought only one would be important," said Fan.

Enzymes actions are redundant

However, he, Richards and their colleagues found the activities of the two kinases are redundant in fertility. To disrupt fertility, they had to knock out the activity of both enzymes in specific ovarian somatic cells. (ERK1/2 are found in all tissues of the body. Richards and Fan were able to disrupt them selectively in ovarian cells required for fertility.)

In women and other female mammals, oocytes exist within the follicles of the ovary, surrounded by granulosa and cumulus cells. Women can only release fertilizable eggs when the follicles grow and the granulose cells differentiate. The oocytes mature and are released through the process of ovulation. Luteinizing hormone (LH) plays a key role in initiating these activities, but this work demonstrates that LH and the canonical pathway it ignites are not the only important elements.

New pathway

"For a long time, people thought that the canonical pathway involving the luteinizing hormone, cyclic AMP and protein kinase A controls everything. In part, this is true. However, another pathway that involves the signaling protein RAS and ERK1/2 mediates everything downstream of LH-receptor activation," said Richards.

RAS and ERK1/2 are activated "like a bullet," she said, occurring over two hours - just a short but vital period during the entire process of releasing a viable egg.
-end-
Others who took part in this research include Zhilin Liu of BCM, Masayuki Shimada of Hiroshima University in Higashi-Hiroshima, Japan; Esta Sterneck and Peter F. Johnson of the Center for Cancer Research of the National Cancer Institute in Frederick, MD., and Stephen M. Hedrick of the University of California, San Diego.

Funding for this work came from the National Institutes of Health, the Japan Society for the Promotion of Science and the National Cancer Institute.

When the embargo lifts, the report will appear at www.sciencemag.org.For more information on basic science at Baylor College of Medicine, please go to www.bcm.edu/fromthelab

Baylor College of Medicine

Related Fertility Articles from Brightsurf:

What are your chances of having a second IVF baby after fertility treatment for the first?
As the restrictions on fertility clinics start to be lifted and IVF treatment resumes, research published in Human Reproduction journal offers reassuring news to women who have had to delay their treatment for a second IVF baby because of the coronavirus.

Fertility preservation use among transgender adolescents
Transgender adolescents often seek hormonal intervention to achieve a body consistent with their gender identity and those interventions affect reproductive function.

A new way to assess male fertility
Current tests for male fertility include measuring the concentration and motility of spermatozoa.

Male fertility after chemotherapy: New questions raised
Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

Vaping may harm fertility in young women
E-cigarette usage may impair fertility and pregnancy outcomes, according to a mouse study published in the Journal of the Endocrine Society.

Are fertility apps useful?
Researchers at EPFL and Stanford have carried out an analysis of the largest datasets from fertility awareness apps.

Marijuana and fertility: Five things to know
For patients who smoke marijuana and their physicians, 'Five things to know about ... marijuana and fertility' provides useful information for people who may want to conceive.

How could a changing climate affect human fertility?
Human adaptation to climate change may include changes in fertility, according to a new study by an international group of researchers.

Migrants face a trade-off between status and fertility
Researchers from the universities of Helsinki, Turku and Missouri as well as the Family Federation of Finland present the first results from a new, extraordinarily comprehensive population-wide dataset that details the lives of over 160,000 World War II evacuees in terms of integration.

Phthalates may impair fertility in female mice
A phthalate found in many plastic and personal care products may decrease fertility in female mice, a new study found.

Read More: Fertility News and Fertility Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.